Zeitschriftenaufsatz
|
2013
Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms.
Autor:in
Li, Jiannong; Bennett, Keiryn; Stukalov, Alexey; Fang, Bin; Zhang, Guolin; Yoshida, Takeshi; Okamoto, Isamu; Kim, Jae-Young; Song, Lanxi; Bai, Yun; Qian, Xiaoning; Rawal, Bhupendra; Schell, Michael; Grebien, Florian; Winter, Georg; Rix, Uwe; Eschrich, Steven; Colinge, Jacques; Koomen, John; Superti-Furga, Giulio; Haura, Eric B;
Publikationen als Autor:in / Herausgeber:in der Vetmeduni
Journal
Schlagwörter
Antineoplastic Agents/pharmacology; Carbazoles/pharmacology; Cell Line, Tumor; Cell Survival/drug effects; Drug Resistance, Neoplasm/drug effects; Drug Resistance, Neoplasm/genetics*; Drug Synergism; Erlotinib Hydrochloride; Gene Expression Regulation, Neoplastic*; Humans; Mutation*; Neoplasm Proteins/genetics; Neoplasm Proteins/metabolism*; Phosphorylation; Protein Interaction Maps; Protein Kinase Inhibitors/pharmacology; Quinazolines/pharmacology; Receptor, Epidermal Growth Factor/antagonists & inhibitors; Receptor, Epidermal Growth Factor/genetics; Receptor, Epidermal Growth Factor/metabolism*; Staurosporine/analogs & derivatives; Staurosporine/pharmacology;
Dokumententyp
Originalarbeit
ISSN/eISSN
1744-4292 -
10.1038/msb.2013.61
WoS ID
PubMed ID